Hearing Loss Trial, Recruiting (NCT06628414)

Hearing Loss Trial, Recruiting NCT06628414 Sponsor: University of Nottingham Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06628414 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have tinnitus (ringing or noise in the ears) that has no known medical cause and is only heard by the person themselves
People who have a sufficient understanding of English to be able to give informed consent to participate
People who are able to safely receive a type of mild brain stimulation called tDCS (transcranial direct current stimulation)

Who may not be able to join:

People who are under 18 years of age
People who do not have tinnitus, or whose tinnitus is the type that can be heard by others (called objective tinnitus)
People who do not have a sufficient understanding of English to be able to give informed consent
People who are unable to safely receive tDCS, as determined by a tDCS safety questionnaire completed at the trial site
People who have taken part in a research study within the last 3 months that involved invasive procedures or payment for participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Magdalena Sereda, PhD, University of Nottingham

Phone: 00441158232625

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06628414

Sponsor: University of Nottingham

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 00441158232625

More information: https://clinicaltrials.gov/study/NCT06628414

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have tinnitus (ringing or noise in the ears) that has no known medical cause and is only heard by the person themselves
People who have a sufficient understanding of English to be able to give informed consent to participate
People who are able to safely receive a type of mild brain stimulation called tDCS (transcranial direct current stimulation)

Who may not be able to join:

People who are under 18 years of age
People who do not have tinnitus, or whose tinnitus is the type that can be heard by others (called objective tinnitus)
People who do not have a sufficient understanding of English to be able to give informed consent
People who are unable to safely receive tDCS, as determined by a tDCS safety questionnaire completed at the trial site
People who have taken part in a research study within the last 3 months that involved invasive procedures or payment for participation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Nottingham

Registry

ClinicalTrials.gov

Start date

1 December 2024

Est. completion

1 September 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Proof of concept

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov